FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
CAMBRIDGE, Mass., March 22, 2016 -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it will be releasing its fourth quarter and full year 2015 financial results after the market close on Tuesday, March 29, 2016. The full text of the earnings release also will be available on the Company’s website at www.metabolix.com.
The Company will host a conference call on the same day at 4:30 p.m. (ET), during which senior management will provide an update on the business and answer questions from the investment community.
While shareholders participate in the call in listen-only mode, Metabolix invites shareholders to submit questions for consideration to [email protected] with the subject line: “Questions for Fourth Quarter Call.” Questions submitted in advance of the call will be reviewed and certain of them may be addressed in management's prepared remarks or in the Q&A portion of the call.
A live webcast of the call with slides can be accessed through the “Investors” section of the Company’s website at www.metabolix.com. To participate in the call, dial toll-free (877) 709-8150 or (201) 689-8354 (international). Interested parties unable to participate in the live call may access an archived version of the webcast on the Company’s website. To listen to a telephonic replay of the conference call, dial toll-free (877) 660-6853 or (201) 612-7415 (international) and enter passcode 13630506. The replay will be available beginning at 7:30 p.m. (ET) on Tuesday, March 29, 2016 and will last through 11:59 p.m. (ET) on Monday, April 11, 2016. In addition, the webcast will be archived on the Company’s website in the investor relations section.
About Metabolix
Metabolix, Inc. is an innovation-driven specialty materials company focused on delivering high- performance biopolymer solutions to customers in the plastics industry. Metabolix’s Mirel® biopolymers, which are derived from renewable resources, are a family of biobased performance additives and specialty resins based on PHA (polyhydroxyalkanoates). Metabolix's proprietary biotechnology platform enables the creation of specialty biopolymers for use in a broad range of applications such as construction and packaging materials, as well as industrial, consumer and personal care products.
For more information, please visit www.metabolix.com. (MBLX-E)
Metabolix Contact: Lynne H. Brum, (617) 682-4693, [email protected]
